Form EFFECT Enlivex Therapeutics
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 2, 2026 4:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enlivex cuts 60% of workforce to focus on knee OA trial
- AthleteMerch.com Launches Mobile App That Puts a Pro-Level Merch Store in Every Athlete's Pocket
- Planet Launches Pelican-12 Satellite
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share